Compare AU

Compare DRUG vs. IHWL

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the iShares Core MSCI World Ex Aus Esg (Aud Hed) ETF (IHWL). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

IHWL

Popularity

Low

Low

Pearlers invested

64

43

Median incremental investment

$943.50

$1,877.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,953.44

$3,666.56

Average age group

26 - 35

26 - 35


Key Summary

DRUG

IHWL

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

IHWL.AX was created on 2016-04-22 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to provide investors with the performance of the MSCI World Investable Market AUD Hedged Index, before fees and expenses. The index is designed to measure the AUD hedged performance of global, developed market large-, mid- and small-capitalisation companies.

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

NVIDIA CORP (9.88 %)

MICROSOFT CORP (8.59 %)

ALPHABET INC CLASS A (2.79 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Information Technology (27.81 %)

Financials (14.85 %)

Health Care (11.91 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

United States (74.50 %)

Japan (6.43 %)

United Kingdom of Great Britain and Northern Ireland (3.39 %)

Management fee

0.57 %

0.19 %


Key Summary

DRUG

IHWL

Issuer

BetaShares

iShares

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

MSCI World IMI 100% Hedged to AUD Net Variant

Asset class

ETF

ETF

Management fee

0.57 %

0.19 %

Price

$8.36

$54.00

Size

$197.947 million

$516.860 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

1.90 %

3.57 %

Market

ASX

ASX

First listed date

08/08/2016

28/04/2016

Purchase fee

$6.50

$6.50


Community Stats

DRUG

IHWL

Popularity

Low

Low

Pearlers invested

64

43

Median incremental investment

$943.50

$1,877.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,953.44

$3,666.56

Average age group

26 - 35

26 - 35


Pros and Cons

DRUG

IHWL

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

DRUG

IHWL

Lower exposure to US market

Higher exposure to US market

Higher management fee

Lower management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home